+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Oncology Market by Animal Type, Treatment Mode, Cancer Type, End User - Global Forecast to 2030- Product Image
Veterinary Oncology Market by Animal Type, Treatment Mode, Cancer Type, End User - Global Forecast to 2030- Product Image
Sale

Veterinary Oncology Market by Animal Type, Treatment Mode, Cancer Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305503
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Oncology Market grew from USD 429.72 million in 2024 to USD 475.20 million in 2025. It is expected to continue growing at a CAGR of 10.29%, reaching USD 773.59 million by 2030.

Navigating the Veterinary Oncology Frontier with Precision and Care

Veterinary oncology stands at a pivotal juncture where scientific breakthroughs converge with escalating demand from pet owners prioritizing their companions’ health. Advances in diagnostic imaging have sharpened our ability to detect neoplastic conditions earlier, while precision therapies are redefining treatment paradigms. This introduction outlines the critical factors driving momentum across the veterinary oncology sector, from evolving clinical protocols to the integration of novel modalities. It frames the overarching landscape, highlighting how demographic shifts in pet ownership and rising expenditures on animal health are creating fertile ground for innovation and investment. In so doing, it sets the stage for an executive summary that synthesizes transformative changes, regulatory influences, segmentation dynamics, and strategic imperatives poised to shape the market trajectory over the coming years.

Catalyzing Evolution: Transformative Shifts Shaping Veterinary Oncology

The veterinary oncology landscape is undergoing a rapid metamorphosis fueled by breakthroughs in immunological science and digital health integration. Cutting-edge therapies once exclusive to human oncology are being repurposed for companion animals, expanding the therapeutic arsenal beyond conventional cytotoxic regimens. Personalized medicine is gaining traction as genomic profiling becomes more accessible in veterinary clinics, enabling targeted treatment strategies. Concurrently, telemedicine platforms are enhancing access to specialist consultations, reducing geographic barriers and accelerating diagnostic workflows. Cross-disciplinary collaboration between oncologists, surgeons, radiologists, and pharmacologists is forging holistic care pathways that elevate treatment efficacy and quality of life. As stakeholders adapt to these shifts, they are redefining best practices and setting new benchmarks for clinical outcomes in veterinary oncology.

United States Tariffs 2025 Impact on Oncology Supply Chains

The introduction of new tariff structures in 2025 has exerted a multidimensional impact on the veterinary oncology supply chain within the United States. Import duties on specialized oncology pharmaceuticals and advanced diagnostic equipment have incrementally increased acquisition costs for veterinary practices and specialty centers. These elevated costs have prompted procurement teams to recalibrate sourcing strategies, exploring alternative suppliers and optimizing inventory management. Some clinics have expedited partnerships with domestic manufacturers to mitigate exposure to volatile tariff policies, while distributors are negotiating longer-term contracts to stabilize pricing. Despite these headwinds, investment in research and development has not waned; instead, stakeholders are seeking innovative financial models and strategic alliances to preserve access to cutting-edge therapies. The net effect is a more resilient, diversified supply network capable of withstanding regulatory fluctuations.

Decoding Market Dynamics Through Targeted Segmentation Insights

Insight into veterinary oncology is greatly enriched by examining market segments defined by animal type, treatment modality, cancer classification, and end user. When considering animal type, the comparative treatment protocols and therapeutic investments between cats and dogs reveal distinct spending patterns and technology adoption rates. Analyzing treatment modes-from chemotherapy through its subclasses of alkylating agents, antimetabolites, cytotoxic agents, and vinca alkaloids, to immunotherapy with its subcategories of cancer vaccines and monoclonal antibodies, as well as radiotherapy subdivisions of brachytherapy and external beam radiotherapy, alongside surgery and targeted therapy-uncovers divergent growth trajectories within each therapeutic class. Delving into cancer types such as hemangiosarcoma, lymphoma, mammary carcinoma, mast cell tumors, and osteosarcoma illuminates which malignancies dominate clinical caseloads and where unmet needs remain pronounced. Finally, understanding the roles played by academic institutions, clinics, online pharmacies, specialty centers, and veterinary hospitals provides clarity on distribution channels, service delivery models, and the evolving ecosystem of stakeholders shaping veterinary oncology.

Regional Dynamics Driving Veterinary Oncology Growth Globally

Regional analysis reveals that the Americas maintain leadership in veterinary oncology adoption due to high pet healthcare spending, mature reimbursement structures, and established research infrastructure. Within Europe, Middle East & Africa, divergent regulatory frameworks and varying levels of clinical specialty development create a complex mosaic of opportunities and challenges; advanced oncology centers in Western Europe drive innovation, while emerging markets across the Middle East and Africa present untapped potential. The Asia-Pacific region, characterized by rapid urbanization and growing pet ownership, is witnessing accelerated uptake of modern cancer therapies, supported by government initiatives to strengthen veterinary healthcare capacity. Supply chain enhancements, cross-border collaborations, and localized clinical trials are further catalyzing growth across these regions, underscoring the geographic diversity of drivers and barriers in the veterinary oncology sector.

Competitive Landscape: Key Players Steering Innovation in Veterinary Oncology

The competitive arena in veterinary oncology features a blend of specialized biopharmaceutical firms, established animal health companies, and niche technology providers. Leaders in oncology pipeline development are advancing immunotherapies and targeted agents specifically validated for companion animals. Simultaneously, clinical service providers are differentiating through integrated care models that combine diagnostics, therapeutic delivery, and long-term monitoring. Distributors and online pharmacy platforms are vying to expand market reach, leveraging digital channels and value-added services to attract veterinary practitioners. Collaborative research partnerships between academia and industry are accelerating the translation of novel therapies from bench to clinic. These dynamics underscore a fiercely innovative landscape where strategic positioning, clinical expertise, and robust supply networks determine market leadership.

Strategic Imperatives: Actionable Recommendations for Industry Leaders

Industry leaders seeking to capitalize on the veterinary oncology market’s momentum should prioritize strategic investments in precision medicine platforms and companion diagnostics tailored to animal genomes. Establishing partnerships with academic centers and contract research organizations will accelerate translational research and enhance product pipelines. To mitigate supply chain vulnerabilities, companies must diversify sourcing strategies and explore localized manufacturing for critical pharmaceuticals. Enhancing digital engagement through telemedicine solutions and data analytics will improve patient outcomes and drive practice-level efficiency. Additionally, cultivating educational programs for veterinary professionals on emerging therapies will foster early adoption and bolster market penetration. By adopting a proactive stance on regulatory compliance and payer advocacy, organizations can shape favorable policy environments and ensure sustainable growth.

Robust Research Methodology Underpinning Actionable Market Intelligence

This research synthesizes primary and secondary data to deliver rigorous, actionable insights. Primary data collection included in-depth interviews with veterinary oncologists, pharmaceutical executives, and practice administrators, ensuring firsthand perspectives on clinical trends and commercial strategies. Secondary research encompassed peer-reviewed journals, industry white papers, patent filings, regulatory documents, and financial reports to contextualize market developments. A robust analytical framework integrated SWOT analyses, Porter’s Five Forces, and proprietary growth matrices to assess competitive intensity and investment opportunities. Qualitative findings were triangulated with quantitative observations to validate conclusions. Ongoing verification through expert advisory panels ensured methodological rigor and relevance. Altogether, this comprehensive approach underpins the reliability and strategic value of the market intelligence presented herein.

Synthesis and Strategic Imperatives for Veterinary Oncology Stakeholders

In conclusion, veterinary oncology is poised for transformative growth driven by technological innovations, shifting regulatory landscapes, and evolving clinical practices. The convergence of personalized medicine, enhanced diagnostic capabilities, and strategic partnerships is setting new standards of care for companion animals diagnosed with cancer. While tariff-induced pressures require adaptive supply chain strategies, they also foster resilience and diversification. Segmentation insights reveal nuanced opportunities across animal types, treatment modalities, cancer classifications, and end users, while regional analysis highlights differential growth trajectories and strategic entry points. Market leaders equipped with data-driven recommendations and a keen understanding of competitive dynamics will be well-positioned to shape the future of veterinary oncology, delivering improved outcomes for pets and sustainable value for stakeholders.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Cats
    • Dogs
  • Treatment Mode
    • Chemotherapy
      • Alkylating Agents
      • Antimetabolites
      • Cytotoxic Agents
      • Vinca Alkaloids
    • Immunotherapy
      • Cancer Vaccines
      • Monoclonal Antibodies
    • Radiotherapy
      • Brachytherapy
      • External Beam Radiotherapy
    • Surgery
    • Targeted Therapy
  • Cancer Type
    • Hemangiosarcoma
    • Lymphoma
    • Mammary Carcinoma
    • Mast Cell Tumors
    • Osteosarcoma
  • End User
    • Academic Institutions
    • Clinics
    • Online Pharmacies
    • Specialty Centers
    • Veterinary Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Zoetis Inc
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • IDEXX Laboratories, Inc.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Oncology Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
9. Veterinary Oncology Market, by Treatment Mode
9.1. Introduction
9.2. Chemotherapy
9.2.1. Alkylating Agents
9.2.2. Antimetabolites
9.2.3. Cytotoxic Agents
9.2.4. Vinca Alkaloids
9.3. Immunotherapy
9.3.1. Cancer Vaccines
9.3.2. Monoclonal Antibodies
9.4. Radiotherapy
9.4.1. Brachytherapy
9.4.2. External Beam Radiotherapy
9.5. Surgery
9.6. Targeted Therapy
10. Veterinary Oncology Market, by Cancer Type
10.1. Introduction
10.2. Hemangiosarcoma
10.3. Lymphoma
10.4. Mammary Carcinoma
10.5. Mast Cell Tumors
10.6. Osteosarcoma
11. Veterinary Oncology Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Clinics
11.4. Online Pharmacies
11.5. Specialty Centers
11.6. Veterinary Hospitals
12. Americas Veterinary Oncology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Veterinary Oncology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Veterinary Oncology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc
15.3.2. Elanco Animal Health Incorporated
15.3.3. Merck & Co., Inc.
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. IDEXX Laboratories, Inc.
15.3.8. Vetoquinol S.A.
15.3.9. Dechra Pharmaceuticals PLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VETERINARY ONCOLOGY MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY ONCOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VETERINARY ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ALKYLATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CYTOTOXIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VINCA ALKALOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 56. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 57. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 58. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 59. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 100. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 101. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 102. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 105. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 107. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 108. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 109. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 119. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 120. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 121. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 122. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 123. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 124. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 128. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 130. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 144. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 145. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 151. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 152. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 156. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 169. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 170. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 171. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 172. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 173. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 177. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 178. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 179. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 180. FINLAND VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 186. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 187. SWEDEN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 198. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 199. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 200. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 201. EGYPT VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 203. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 205. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 206. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 207. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 208. TURKEY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 219. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 220. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 221. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 222. NORWAY VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 225. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 226. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 227. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 228. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 229. POLAND VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 247. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 248. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 249. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 250. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 251. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 253. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 254. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 255. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 256. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 257. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 258. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 262. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 263. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 264. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 265. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 290. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 291. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 292. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 293. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 299. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 300. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 313. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 314. SINGAPORE VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 320. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 321. VIETNAM VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY TREATMENT MODE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 327. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 328. TAIWAN VETERINARY ONCOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. VETERINARY ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 330. VETERINARY ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Veterinary Oncology market report include:
  • Zoetis Inc
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • IDEXX Laboratories, Inc.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 475.2 Million
Forecasted Market Value ( USD ) by 2030 $ 773.59 Million
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type, By Therapy, By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type, By Therapy, By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Veterinary Oncology - Global Strategic Business Report - Product Image

Veterinary Oncology - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Veterinary Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Veterinary Oncology Market Report 2025 - Product Image

Veterinary Oncology Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Veterinary Oncology Market

Veterinary Oncology is a specialized field of veterinary medicine that focuses on the diagnosis and treatment of cancer in animals. Veterinary oncologists are trained to diagnose and treat a variety of cancers, including lymphoma, mast cell tumors, and bone cancer. Treatment options may include chemotherapy, radiation therapy, and surgery. Veterinary oncologists also provide supportive care to help animals cope with the side effects of cancer treatment. Veterinary oncology is an important part of animal healthcare, as cancer is a leading cause of death in animals. Veterinary oncologists work closely with other veterinary specialists, such as surgeons and radiologists, to provide comprehensive care for animals with cancer. Some companies in the Veterinary Oncology market include VetDC, VetCancer, and VetCure Oncology. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.